PHASE I TRIAL OF MURINE ANTI-GANGLIOSIDE (GD2) MONOCLONAL ANTIBODY (Mab) 14G2A IN CANCER PATIENTS
1992 ◽
Vol 11
(2)
◽
pp. 135
◽
1997 ◽
Vol 33
◽
pp. S249-S250
◽